Seres Therapeutics, Inc. (MCRB)

SEC filing

Seres Therapeutics, Inc.

MCRB · CIK 1609809

4 · Nov 18, 2025 · Henn Matthew R sold 1,257 shares at $17.30/share ($21,746); exercised options for 4,236 shares

Henn Matthew R sold 1,257 shares at $17.30/share ($21,746); exercised options for 4,236 shares

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).